Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials

(2012) Peter M Rothwell et al.   LANCET

Cigarette smoking and the risk of incident and fatal melanoma in a large prospective cohort study

(2011) John Oliver DeLancey et al.   CANCER CAUSES & CONTROL

Calcium Plus Vitamin D Supplementation and the Risk of Nonmelanoma and Melanoma Skin Cancer: Post Hoc Analyses of the Women's Health Initiative Randomized Controlled Trial

(2011) Jean Y. Tang et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Use of Nonsteroidal Anti-inflammatory Drugs Decreases the Risk of Cutaneous Melanoma: Results of a United States Case–Control Study

(2011) Clara Curiel-Lewandrowski et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

(2011) John Burn et al.   LANCET

Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer

(2010) Wenjing Tian et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

(2010) Peter M Rothwell et al.   LANCET

Incident Invasive Breast Cancer, Geographic Location of Residence, and Reported Average Time Spent Outside

(2009) A. E. Millen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Non-Steroidal Anti-Inflammatory Drugs and Melanoma Risk: Large Dutch Population-Based Case–Control Study

(2009) Arjen Joosse et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Aspirin, salicylates, and cancer

(2009) Peter C Elwood et al.   LANCET

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

(2009) Jack Cuzick et al.   LANCET ONCOLOGY

COX-2 expression in malignant melanoma: a novel prognostic marker?

(2009) Maria R. Becker et al.   MELANOMA RESEARCH

Recall Bias in Melanoma Risk Factors and Measurement Error Effects: A Nested Case-Control Study Within the Norwegian Women and Cancer Study

(2008) C. L. Parr et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Invited Commentary: Recall Bias in Melanoma--Much Ado About Almost Nothing?

(2008) O. Gefeller   AMERICAN JOURNAL OF EPIDEMIOLOGY

A Large Cohort Study of Nonsteroidal Anti-inflammatory Drug Use and Melanoma Incidence

(2008) M. M. Asgari et al.   JNCI-Journal of the National Cancer Institute

Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines

(2008) Nikhil M. Vad et al.   MELANOMA RESEARCH